Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Supporters often stress the opportunity for meaningful therapeutic gains, principally in conditions where conventional medications have proven inadequate. However, this is to consider the significant financial burden associated with CPI stem cell thera